Elucidata Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
180
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
7
Elucidata General Information
Description
Developer of a data analytics platform designed to analyze omics datasets to understand the molecular basis of cellular phenotypes. The company's platform can process, analyze, and visualize large omics data across metabolic, genomics, transcriptomic, and proteomics, among others, to transform decision-making processes in drug research and development, enabling scientists and doctors to discover treatments for diseases efficiently.
Contact Information
Website
www.elucidata.ioCorporate Office
- 2261 Market Street
- Suite 10296
- San Francisco, CA 94114
- United States
Corporate Office
- 2261 Market Street
- Suite 10296
- San Francisco, CA 94114
- United States
Elucidata Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Accelerator/Incubator | 01-May-2026 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series A) | 21-Sep-2022 | Completed | Generating Revenue | |||
| 2. Seed Round | 28-Jan-2021 | $5M | $6.7M | Completed | Generating Revenue | |
| 1. Seed Round | 09-May-2018 | $1.7M | $1.7M | Completed | Generating Revenue |
Elucidata Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-2 | ||||||||
| Series A-1 | ||||||||
| Pre-Series A2 | ||||||||
| Pre-Series A1 | 526,689 | $0.000100 | $2 | $2 | 1x | $2 | 4% | |
| Seed | 800,583 | $0.000100 | $2.12 | $2.12 | 1x | $2.12 | 6.08% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Elucidata Comparisons
Industry
Financing
Details
Elucidata Competitors (1)
One of Elucidata’s competitors is DNAnexus, a Venture Capital-Backed company based in San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| DNAnexus | Venture Capital-Backed | San Francisco, CA |
Elucidata Signals
Elucidata Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Anthropic AWS Agentic AI Accelerator | Accelerator/Incubator | |||
| Eight Roads | Corporate Venture Capital | Minority | ||
| F-Prime | Venture Capital | Minority | ||
| TiE SoCal Angels | Angel Group | Minority | ||
| Anvaya Ventures | Venture Capital | Minority |
Elucidata FAQs
-
When was Elucidata founded?
Elucidata was founded in 2015.
-
Where is Elucidata headquartered?
Elucidata is headquartered in San Francisco, CA.
-
What is the size of Elucidata?
Elucidata has 180 total employees.
-
What industry is Elucidata in?
Elucidata’s primary industry is Discovery Tools (Healthcare).
-
Is Elucidata a private or public company?
Elucidata is a Private company.
-
What is Elucidata’s current revenue?
The current revenue for Elucidata is .
-
How much funding has Elucidata raised over time?
Elucidata has raised $22.7M.
-
Who are Elucidata’s investors?
Anthropic AWS Agentic AI Accelerator, Eight Roads, F-Prime, TiE SoCal Angels, and Anvaya Ventures are 5 of 7 investors who have invested in Elucidata.
-
Who are Elucidata’s competitors?
DNAnexus is a competitor of Elucidata.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process